Assessment of LBR-101 In Chronic Migraine
- Study Title
- Assessment of LBR-101 In Chronic Migraine
- Teva Identifier
- LBR-101-021
- ClinicalTrials.gov Identifier
- NCT02021773
- Study Status
- Completed
- Trial Condition(s)
- Chronic Migraine
- Interventions
- Biological: LBR-101 High Dose | Biological: LBR-101 Low Dose | Biological: Placebo
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 18 Years to 65 Years
- Trial Duration
- 01/01/2014 - 03/01/2015
- Phase
- Phase 2
